Cargando…
Intra‐Target Microdosing – A Novel Drug Development Approach: Proof of Concept, Safety, and Feasibility Study in Humans
Intra‐Target Microdosing (ITM) is a novel drug development approach aimed at increasing the efficiency of first‐in‐human (FIH) testing of new molecular entities (NMEs). ITM combines intra‐target drug delivery and “microdosing,” the subpharmacological systemic exposure. We hypothesized that when the...
Autores principales: | Burt, T, MacLeod, D, Lee, K, Santoro, A, DeMasi, DK, Hawk, T, Feinglos, M, Rowland, M, Noveck, RJ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593161/ https://www.ncbi.nlm.nih.gov/pubmed/28689370 http://dx.doi.org/10.1111/cts.12477 |
Ejemplares similares
-
Intra‐Target Microdosing (ITM): A Novel Drug Development Approach Aimed at Enabling Safer and Earlier Translation of Biological Insights Into Human Testing
por: Burt, T, et al.
Publicado: (2017) -
Microdosing: Concept, Application and Relevance
por: Tewari, Tushar, et al.
Publicado: (2010) -
Pediatric Microdose Study of [(14)C]Paracetamol to Study Drug Metabolism Using Accelerated Mass Spectrometry: Proof of Concept
por: Mooij, Miriam G., et al.
Publicado: (2014) -
Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development
por: Burt, T, et al.
Publicado: (2016) -
Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers
por: Hutten, Nadia R. P. W., et al.
Publicado: (2019)